⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18707478 | 1.00 | — | — | |
| SCHEMBL2742874 | 0.86 | — | — | |
| SCHEMBL14366959 | 0.86 | — | — | |
| SCHEMBL16543651 | 0.86 | — | — | |
| SCHEMBL18707515 | 0.86 | — | — | |
| SCHEMBL18233149 | 0.85 | — | — | |
| SCHEMBL1642430 | 0.77 | — | — | |
| SCHEMBL13706079 | 0.77 | TLR4 (0.31) | — | |
| SCHEMBL12674234 | 0.77 | — | — | |
| SCHEMBL10005840 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9610362-B2 | Antisense conjugates for decreasing expression of DMPK | VALERION THERAPEUTICS, LLC (US) | 2017-04-04 | — | — | US | disclosed |
| US-9610362-B2 | Antisense conjugates for decreasing expression of DMPK | VALERION THERAPEUTICS, LLC (US) | 2017-04-04 | — | — | US | disclosed |
| US-20160331814-A1 | Col 11A1 AND NOVEL FRAGMENT THEREOF FOR REGULATION OF BONE MINERALIZATION | BOISE STATE UNIVERSITY | 2016-11-17 | — | — | US | disclosed |
| US-20150064181-A1 | ANTISENSE CONJUGATES FOR DECREASING EXPRESSION OF DMPK | VALERION THERAPEUTICS, LLC (US) | 2015-03-05 | — | — | US | disclosed |
| US-20150064181-A1 | ANTISENSE CONJUGATES FOR DECREASING EXPRESSION OF DMPK | VALERION THERAPEUTICS, LLC (US) | 2015-03-05 | — | — | US | disclosed |